Carrier Screening Market Size, Share, Statistics, Trends, Business Opportunities, Key Players

The Global Carrier Screening Market report offers in-depth information and assessment of the key statistical data pertaining to the Carrier Screening market size, share, growth factors, key drivers, restraints, growth prospects, current and emerging trends, and other vital information. The report has been generated through deep and thorough primary and secondary research with the crucial statistical data validated and verified from industry experts, analysts, and professionals. The report contains abridged information about historical, current, and forecast estimation of each sector, segment, and region of the Global Carrier Screening market. The report further includes an insightful coverage of the key players of the Carrier Screening market along with extensive research on their business strategies and expansion plans.

Key Highlights From The Report.

· In November 2019, Asuragen, a molecular diagnostics company based out of the U.S. launched the AmplideX® PCR/CE SMN1/2 Plus Kit. The technology helps in the early detection of variants associated with SMN1 gene duplication events as well as quantify numbers related to SMN1 and SMN2. By providing results from a single PCR reaction, the technology helps to increase efficiency by reducing time and effort.

· Over the forecast period, the DNA sequencing segment is anticipated to witness the highest market share in terms of revenue in the carrier screening market because of the number of patents rising on an incremental scale across European and North American regions. Additionally, the awareness regarding the advantages of diagnosing critical diseases early is increasing, thereby driving the growth of the market.

· In terms of revenue, North America held the largest market share in 2019 which can be attributed to the increasing number of tests conducted in order to analyze whether an individual is carrying the gene for an inherited disease. The major competitors across the globe are emphasising on the development of healthcare infrastructure. Over the coming years, Asia Pacific is expected to register the highest CAGR of 18.4% throughout the forecasted period as people in India, China, and Australia are becoming aware of genetic diseases and screening tests.

· Key participants MedGenome Inc., Luminex Corporation, Illumina Inc., Otogenetics Corporation, Myriad Genetics Inc., Thermo Fisher Scientific Inc., Natera Inc., Gene By Gene Ltd., Corporation of America Holdings, and Mount Sinai Genomics Inc., among others.

The report begins with basic information about the market, such as definitions, applications, classifications, value chain analysis, among others, to facilitate a better understanding among the readers. The market offers a panoramic view of the industry through a thorough analysis of the key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Detailed Analysis of the Regions of the Carrier Screening Market Include Regions such as:

· North America (U.S., Canada)

· Europe (U.K., Italy, Germany, France, Rest of EU)

· Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

· Latin America (Chile, Brazil, Argentina, Rest of Latin America)

· Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/carrier-screening-market

Thank you for reading our report. To know more about the customization of the report or further queries about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements.